STAT News
statnews.com

Reporting from the frontiers of health and medicine

STAT+: NIH proposal to cap research grants draws mixed reception, agency says

STAT1 min read
Read on Scour →
Feeds

New guidelines on migraine prevention reflect increasing options for patients

STAT4 min read
Read on Scour →
Feeds

Trump strikes nine more deals with drugmakers to lower prices

STAT2 min read
Read on Scour →
Feeds

STAT+: Can buying a drug patent application be seen as a bid to prolong a monopoly?

STAT1 min read
Read on Scour →
Feeds

STAT+: GLP-1 drugs are almost single-handedly forcing employers to reconsider workers’ health care

STAT1 min read
Read on Scour →
Feeds

STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and more

STAT1 min read
Read on Scour →
Feeds

STAT+: Can a pregnancy hormone steer a cardiovascular treatment?

STAT
Read on Scour →
Feeds

A winner, a loser, and a mid-stage signal from a major cardiology research conference

STAT5 min read
Read on Scour →
Feeds

Opinion: The most shocking thing about the latest statistics on CTE in football is that we find them so shocking

STAT4 min read
Read on Scour →
Feeds

STAT+: After a rough stretch, mRNA gets a boost — at least for now

STATHN1 min read
Read on Scour →
Feeds

STAT+: Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy

STAT1 min read
Read on Scour →
Feeds

STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer

STAT1 min read
Read on Scour →
Feeds

STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua

STAT
Read on Scour →
Feeds

STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?

STAT
Read on Scour →
Feeds

Juul gets OK to sell updated vaping device with age-gating technology

STAT1 min read
Read on Scour →
Feeds

Opinion: The unintended consequences of the Lindsay Clancy case

STAT3 min read
Read on Scour →
Feeds

STAT+: Up and down the ladder: The latest comings and goings

STAT1 min read
Read on Scour →
Feeds

STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

STAT
Read on Scour →
Feeds

At a federal autism advisory committee meeting, members double down on long-debunked theories

STAT3 min read
Read on Scour →
Feeds

STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more

STAT1 min read
Read on Scour →
Feeds

Keyboard shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post actions

Love post
a
Like post
l
Dislike
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help